Style | Citing Format |
---|---|
MLA | Soleimani A, et al.. "The Effect of Moderate-Intensity Aerobic Exercise on Non-Proliferative Diabetic Retinopathy in Type Ii Diabetes Mellitus Patients: A Clinical Trial." Microvascular Research, vol. 149, no. , 2023, pp. -. |
APA | Soleimani A, Soltani P, Karimi H, Mirzaei M, Esfahanian F, Yavari M, Esfahani MP (2023). The Effect of Moderate-Intensity Aerobic Exercise on Non-Proliferative Diabetic Retinopathy in Type Ii Diabetes Mellitus Patients: A Clinical Trial. Microvascular Research, 149(), -. |
Chicago | Soleimani A, Soltani P, Karimi H, Mirzaei M, Esfahanian F, Yavari M, Esfahani MP. "The Effect of Moderate-Intensity Aerobic Exercise on Non-Proliferative Diabetic Retinopathy in Type Ii Diabetes Mellitus Patients: A Clinical Trial." Microvascular Research 149, no. (2023): -. |
Harvard | Soleimani A et al. (2023) 'The Effect of Moderate-Intensity Aerobic Exercise on Non-Proliferative Diabetic Retinopathy in Type Ii Diabetes Mellitus Patients: A Clinical Trial', Microvascular Research, 149(), pp. -. |
Vancouver | Soleimani A, Soltani P, Karimi H, Mirzaei M, Esfahanian F, Yavari M, et al.. The Effect of Moderate-Intensity Aerobic Exercise on Non-Proliferative Diabetic Retinopathy in Type Ii Diabetes Mellitus Patients: A Clinical Trial. Microvascular Research. 2023;149():-. |
BibTex | @article{ author = {Soleimani A and Soltani P and Karimi H and Mirzaei M and Esfahanian F and Yavari M and Esfahani MP}, title = {The Effect of Moderate-Intensity Aerobic Exercise on Non-Proliferative Diabetic Retinopathy in Type Ii Diabetes Mellitus Patients: A Clinical Trial}, journal = {Microvascular Research}, volume = {149}, number = {}, pages = {-}, year = {2023} } |
RIS | TY - JOUR AU - Soleimani A AU - Soltani P AU - Karimi H AU - Mirzaei M AU - Esfahanian F AU - Yavari M AU - Esfahani MP TI - The Effect of Moderate-Intensity Aerobic Exercise on Non-Proliferative Diabetic Retinopathy in Type Ii Diabetes Mellitus Patients: A Clinical Trial JO - Microvascular Research VL - 149 IS - SP - EP - PY - 2023 ER - |